Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
EARLY_PHASE1
100 participants
INTERVENTIONAL
2023-11-30
2024-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Determination of Labor Progression Patterns Using Non-invasive, Ultrasound Based+Continuous Vacuum Mode
NCT01042483
Association Between Fluid Administration, Oxytocin Administration, and Fetal Heart Rate Changes
NCT02121184
Amnioinfusion Initiative
NCT00787163
Does Ultrasound Help With Placement of Labor Analgesia in Pregnant Patients?
NCT02207972
Fetal Heart Rate Changes and Labor Neuraxial Analgesia: a Machine Learning Approach
NCT05399979
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intrauterine pressure catheter (IUPC) present
An IUPC is placed through the standard of care.
Intrauterine pressure catheter (IUPC) present
Amniotic fluid will be analyzed every 3 hours for the duration of labor for patients who require an IUPC through the standard of care.
Intrauterine pressure catheter (IUPC) absent
No IUPC is required
Intrauterine pressure catheter (IUPC) absent
Patients that do not require an IUPC through the standard of care will not have amniotic fluid analyzed.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intrauterine pressure catheter (IUPC) present
Amniotic fluid will be analyzed every 3 hours for the duration of labor for patients who require an IUPC through the standard of care.
Intrauterine pressure catheter (IUPC) absent
Patients that do not require an IUPC through the standard of care will not have amniotic fluid analyzed.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Gestational age ≥ 37 weeks
* Age of participant ≥ 18 years old
Exclusion Criteria
* Gestational age \< 37 weeks
* Intrauterine fetal demise
* Fetal anomalies
* Pre-gestational Diabetics / Gestational Diabetics
* Chronic immune suppression with steroids (defined as \> 1 month of consistent steroid use)
* Oligohydramnios
* Women with documented non-obstetric infections within 2 weeks of admission; including use of any antibiotics within 2 weeks of admission for non-documented/suspected infections
* Repeat temperature not performed within 45 minutes of index fever (100.4 F)
* Index fever (100.4 F) is \> 1 hour after delivery
* Expectantly managed premature rupture of membranes
18 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oregon Health and Science University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Croslanda
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Adam Crosland, MD
Role: PRINCIPAL_INVESTIGATOR
Oregon Health and Science University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oregon Health & Science Univerity
Portland, Oregon, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00024844
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.